Investor seeks access to Bio-Rad books

An investor in life sciences company Bio-Rad, which agreed a US$55 million FCPA-related non-prosecution agreement with the US Department of Justice and the Securities and Exchange Commission in November, has asked the Delaware Chancery Court to force the company to turn over records related to the foreign bribery allegations.

Unlock unlimited access to all Global Investigations Review content